A Dual‐Responsive Morphologically‐Adaptable Nanoplatform for Targeted Delivery of Activatable Photosensitizers in Precision Photodynamic Therapy
Authors:
Abstract
Photodynamic therapy (PDT) is an effective approach for treating melanoma. However, the photosensitizers employed in PDT can accumulate in healthy tissues, potentially causing harm to normal cells and resulting in side effects such as heightened photosensitivity. To address this, an activatable photosensitizer (PSD) by linking PpIX with a fluorescence quencher using a disulfide bond is designed. PSD responded to endogenous GSH, showing high selectivity for A375 cells. To enhance PSD's bioavailability and anticancer efficacy, an enzyme‐responsive nanoplatform based on a lonidamine‐derived self‐assembling peptide is developed. Initially, PSD and the peptide self‐assembled into nanoparticles, displaying potent tumor targeting of PSD in vivo. Upon cell uptake, these nanoparticles specifically responded to elevated cathepsin B, causing nanoparticle disintegration and releasing PSD and lonidamine prodrug (LND‐1). PSD is selectively activated by GSH for cancer‐specific fluorescence imaging and precision PDT, while LND‐1 targeted mitochondria, forming a fibrous lonidamine depot in situ and intensifying photosensitizer's cytotoxicity through ROS generation, mitochondrial dysfunction, and DNA damage. Notably, intravenous administration of LND‐1‐PEG@PSD with light irradiation significantly suppressed A375‐xenografted mouse tumor growth, with minimal systemic toxicity. Together, the synergy of activatable photosensitizer and enzyme‐responsive nanoplatform elevates PDT precision and diminishes side effects, showcasing significant potential in the realm of cancer nanomedicine.Keywords
Funding Information
- National Natural Science Foundation of China (51973234, 82372114)
This publication has 30 references indexed in Scilit:
- Supramolecular photosensitizers rejuvenate photodynamic therapyChemical Society Reviews, 2018
- Intracellular Peptide Self-Assembly: A Biomimetic Approach for in Situ Nanodrug PreparationBioconjugate Chemistry, 2018
- Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic TherapyACS Nano, 2017
- Development of an Azo-Based Photosensitizer Activated under Mild Hypoxia for Photodynamic TherapyJournal of the American Chemical Society, 2017
- Delivery and Release of Small-Molecule Probes in Mitochondria Using Traceless LinkersJournal of the American Chemical Society, 2017
- Host Materials Transformable in Tumor Microenvironment for Homing TheranosticsAdvanced Materials, 2017
- Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug releaseNature Nanotechnology, 2016
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- FRET Quenching of Photosensitizer Singlet Oxygen GenerationThe Journal of Physical Chemistry B, 2009
- A guided tour into subcellular colocalization analysis in light microscopyJournal of Microscopy, 2006